TARGETING METHYLGLYOXAL AND PPAR GAMMA TO ALLEVIATE NEUROPATHIC PAIN ASSOCIATED WITH TYPE 2 DIABETES
Neuropathic pain affects up to 50% of the 29 million diabetic patients in the United States. Neuropathic pain in diabetes manifests as a disease of the peripheral and central nervous systems. The prevalence of type 2 diabetes is far greater than type 1 (90%), yet the overwhelming focus on type 1 mod...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
UKnowledge
2015
|
| Subjects: | |
| Online Access: | https://uknowledge.uky.edu/physiology_etds/24 https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1024&context=physiology_etds |